The primary research goal of the Division of Gastroenterology and Hepatology (GIH) is to create scientific discoveries relevant to gastrointestinal and liver diseases and translate those discoveries into clinical practice. The division supports and maintains fundamental, laboratory-based research programs as well as clinical research programs focused on pathophysiology, epidemiology and the conduct of clinical trials. GIH supports robust career development opportunities for its investigators to ensure future success of its mission of providing the best care to every patient, every day.
In 2007, nearly half of the GIH division's $25 million in research funding came from the National Institutes of Health. Industry partners, nonprofit foundations and Mayo Clinic — as well as generous gifts from our benefactors, patients and families — all support the research mission. In 2007, the division initiated 55 new human clinical trials and published 427 articles, editorials and reviews.
Research topics include the study of treatments for liver and pancreas disease; investigation of new technologies used in the identification and treatment of inflammatory bowel disease, as well as irritable bowel syndrome and other motility disorders; development of a new generation of endoscopes to perform incision-free procedures; and much more.
Support GI Research
Philanthropy provides essential support for GI research. Read about how your gift can advance the discovery of gastrointestinal diseases and disorders treatments.